Revlimid for treating multiple myeloma, get applied to medical insurance benefit

People are paying attention to the effect of Revlimid, to which Ministry of Health and Welfare applied Risk-sharing contract. Celgene expects to establish a new treatment mechanism for multiple myeloma, and expand its indication in domestic.

Celgene Korea prepared the place to share latest treatment knowledge of Multiple Myeloma and Clinical Effect of Revlimid, for celebrating its application ...